Articles by Chitra Sethi - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

Articles by Chitra Sethi

Merck to Cut 17,500 Jobs by 2012

Feb 17, 2010

Merck & Co. (Whitehouse Station, NJ) has announced restructuring plans that include reducing its companywide workforce by 15% by the end of 2012.

Novavax Terminates Negotiations with ROVI Pharmaceuticals for Influenza Vaccine Collaboration

Feb 12, 2010

Novavax will discontinue negotiations for the previously announced collaboration with Madrid-based ROVI Pharmaceuticals.

Watson Pharmaceuticals Acquires Eden Biodesign

Feb 4, 2010

Watson Pharmaceuticals has acquired Eden Biodesign for $15 million.

AstraZeneca Drops the Axe Again and Cuts 8,000 Jobs

Jan 29, 2010

London-based pharmaceutical company AstraZeneca plans to slash 8,000 jobs, or 12% of its work force, by 2014 to cut costs.

Gender Gap is Getting Narrower in the Biopharmaceutical Sector

Jan 15, 2010

The results of BioPharm International's fourth annual salary survey, conducted in the fall of 2009, shows that women lag behind their male counterparts.

Genzyme Outsources Fill-Finish Operations to Hospira

Jan 8, 2010

Genzyme (Cambridge, MA) will outsource fill-and-finish operations for its drugs Cerezyme, Fabrazyme, Myozyme, and Thyrogen to Illinois-based Hospira, Inc.

Can Biopharma Steer Through the Stormy Seas?

The year 2009 was marked by recession, industry megamergers, and venture-capital scarcity. How did biopharmaceutical professionals fare?
Jan 1, 2010

The year 2009 was marked by recession, industry megamergers, and venture-capital scarcity. How did biopharmaceutical professionals fare?

Sanofi Recalls 800,000 Doses of H1N1 (Swine) Flu Vaccine for Children

Dec 16, 2009

Sanofi Pasteur, the vaccines division of France-based Sanofi-Aventis Group, is voluntarily recalling about 800,000 doses of H1N1 (swine) flu vaccine meant for children between the ages of 6 months and 35 months because quality assurance tests indicate the vaccine doses lost some potency.

FDA Approves Agriflu Seasonal Influenza Vaccine

Nov 30, 2009

The US Food and Drug Administration has approved Agriflu, a new seasonal flu vaccine manufactured by Novartis Vaccines and Diagnostics (Siena, Italy), for people ages 18 years and older to prevent disease caused by influenza virus subtypes A and B.

ADVERTISEMENT

ADVERTISEMENT

Click here